Previous Close | 95.88 |
Open | 96.28 |
Bid | 95.60 x 900 |
Ask | 97.68 x 900 |
Day's Range | 96.16 - 97.20 |
52 Week Range | 90.93 - 108.78 |
Volume | |
Avg. Volume | 1,441,393 |
Market Cap | 197.734B |
Beta (5Y Monthly) | 0.46 |
PE Ratio (TTM) | 23.59 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 3.78 (3.94%) |
Ex-Dividend Date | Mar 07, 2024 |
1y Target Est | N/A |
Subscribe to Yahoo Finance Plus to view Fair Value for NVS
Zacks.com users have recently been watching Novartis (NVS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Novartis (NVS) closed at $95.88 in the latest trading session, marking a +0.64% move from the prior day.
Mesoblast (MESO) gains as the FDA states that the available phase III data for lead candidate, remestemcel-L, is sufficient to support a regulatory filing for pediatric SR-aGVHD indication.